XT

XTX Topco Portfolio holdings

AUM $5.75B
1-Year Est. Return 30.58%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+30.58%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$5.75B
AUM Growth
+$1.94B
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
4,587
New
Increased
Reduced
Closed

Top Buys

1 +$34.9M
2 +$20.6M
3 +$18.9M
4
DUK icon
Duke Energy
DUK
+$18.8M
5
BSX icon
Boston Scientific
BSX
+$18.7M

Top Sells

1 +$27.9M
2 +$24M
3 +$17.5M
4
AAPL icon
Apple
AAPL
+$16.9M
5
VTI icon
Vanguard Total Stock Market ETF
VTI
+$15.7M

Sector Composition

1 Financials 14.82%
2 Technology 14.69%
3 Industrials 13.94%
4 Healthcare 11.54%
5 Consumer Discretionary 11.03%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BIO icon
4476
Bio-Rad Laboratories Class A
BIO
$8.23B
-16,108
BITI icon
4477
ProShares Short Bitcoin Strategy ETF
BITI
$115M
-11,836
BJ icon
4478
BJs Wholesale Club
BJ
$11.3B
-47,047
BNED icon
4479
Barnes & Noble Education
BNED
$363M
-32,410
BRX icon
4480
Brixmor Property Group
BRX
$9.31B
-13,652
BTOG icon
4481
Bit Origin
BTOG
$2.93M
-2,812
BVN icon
4482
Compañía de Minas Buenaventura
BVN
$8.7B
-66,358
BVS icon
4483
Bioventus
BVS
$589M
-45,990
BXMT icon
4484
Blackstone Mortgage Trust
BXMT
$3.11B
-20,636
BXP icon
4485
Boston Properties
BXP
$9.9B
-55,644
CARM
4486
DELISTED
Carisma Therapeutics
CARM
-40,097
CAT icon
4487
Caterpillar
CAT
$433B
-6,260
CGNX icon
4488
Cognex
CGNX
$10.8B
-11,275
CI icon
4489
Cigna
CI
$74.2B
-14,410
CLMB icon
4490
Climb Global Solutions
CLMB
$426M
-12,644
CSIQ icon
4491
Canadian Solar
CSIQ
$1.32B
-12,819
CVS icon
4492
CVS Health
CVS
$121B
-15,774
CZR icon
4493
Caesars Entertainment
CZR
$5.96B
-64,427
DUOT icon
4494
Duos Technologies
DUOT
$408M
-32,313
DVA icon
4495
DaVita
DVA
$12.3B
-34,128
EEIQ icon
4496
EpicQuest Education Group
EEIQ
$6.01M
-2,238
EEM icon
4497
iShares MSCI Emerging Markets ETF
EEM
$28.6B
-36,203
EFA icon
4498
iShares MSCI EAFE ETF
EFA
$75.5B
-38,735
FDUS icon
4499
Fidus Investment
FDUS
$713M
-33,519
FHTX icon
4500
Foghorn Therapeutics
FHTX
$220M
-15,662